Experimental and clinical basis for the use of statins in patients with ischemic and nonischemic cardiomyopathy.
about
Statins in heart failure: do we need another trial?The cGMP signaling pathway as a therapeutic target in heart failure with preserved ejection fractionNew data on the clinical impact of exercise training, fish oils, and statins in heart failure.Regulation of oxidative stress and cardioprotection in diabetes mellitus.Effect of pravastatin on echocardiographic circulation parameters in dogs.Statins and myocardial remodelling: cell and molecular pathways.Effects of intensive versus mild lipid lowering by statins in patients with ischemic congestive heart failure: Korean Pitavastatin Heart Failure (SAPHIRE) study.Endothelial p53 deletion improves angiogenesis and prevents cardiac fibrosis and heart failure induced by pressure overload in mice.Simvastatin-induced cardiac autonomic control improvement in fructose-fed female ratsChronic statin administration may attenuate early anthracycline-associated declines in left ventricular ejection functionEffects of Statin Therapy on Clinical Outcomes of Survivors of Acute Myocardial Infarction with Severe Systolic Heart FailureCombined cardiac magnetic resonance imaging and C-reactive protein levels identify a cohort at low risk for defibrillator firings and deathIntensity of statin therapy and new hospitalizations for heart failure in patients with type 2 diabetes.Pleiotropic effects of long-term monotherapy with rosuvastatin in dogs with moderate heart failureMetabolic dysfunction in diabetic cardiomyopathy.Phenotype-Specific Treatment of Heart Failure With Preserved Ejection Fraction: A Multiorgan Roadmap.Treatment with atorvastatin is associated with a better prognosis in chronic heart failure with systolic dysfunction: results from The Daunia Heart Failure Registry.Pravastatin improves function in hibernating myocardium by mobilizing CD133+ and cKit+ bone marrow progenitor cells and promoting myocytes to reenter the growth phase of the cardiac cell cycle.Autophagy: an affair of the heartSimvastatin preserves diastolic function in experimental hypercholesterolemia independently of its lipid lowering effect.A viewpoint on statin effects − benefits and problemsSimvastatin treatment attenuates increased respiratory variability and apnea/hypopnea index in rats with chronic heart failure.The controversy of a wider statin utilization: why?Activation of sphingosine-1-phosphate signalling as a potential underlying mechanism of the pleiotropic effects of statin therapy.Similarities and differences in patient characteristics between heart failure registries versus clinical trials.Innate immunity and the failing heart: the cytokine hypothesis revisited.Leukocyte diversity in resolving and nonresolving mechanisms of cardiac remodeling.Inhibitory effect of statins on inflammatory cytokine production from human bronchial epithelial cells.Apolipoprotein B100 secretion by cultured ARPE-19 cells is modulated by alteration of cholesterol levels.Effect of atorvastatin in patients with chronic heart failure - insights from randomized clinical trials.Host tissue response in stem cell therapy.Simvastatin prevents large blood pressure variability induced aggravation of cardiac hypertrophy in hypertensive rats by inhibiting RhoA/Ras-ERK pathways.Appropriate candidates for statin use in heart failure.Rosuvastatin added to standard heart failure therapy improves cardiac remodelling in heart failure rats with preserved ejection fraction.Targeting Cholesterol in Non-ischemic Heart Failure: A Role for LDLR Gene Therapy?Waon therapy attenuates cardiac hypertrophy and promotes myocardial capillary growth in hypertensive rats: a comparative study with fluvastatin.Transcriptome analysis of human heart failure reveals dysregulated cell adhesion in dilated cardiomyopathy and activated immune pathways in ischemic heart failure
P2860
Q26998966-5286FA01-424C-49E1-83E6-F4479A8CE951Q27024279-075DFEC5-BBC4-4C6E-8657-D88FD97AD38BQ33521834-D7186DC9-1EF0-475B-AB3C-EF74FC5BF8D1Q33572259-4000CBE0-C403-4C65-B52D-5D5E0C01B252Q33780370-1E25F5EB-47B9-4AEF-B45F-A583F154C4A2Q34196628-16CA9C99-46AB-4298-B4D6-AD754C6E984DQ34451383-7852EDCE-62D1-48B7-B336-F65E2B98585CQ35135731-2D74B15A-94D0-4D32-B46D-5C47886572CFQ35232415-7F466324-5C74-4B91-B2BC-6BCEF3EE206EQ35538919-48727CD1-2E32-4CA3-9077-EBAA31F2E69AQ35866965-915C6E4A-8094-42D3-AFEC-A8D61E89B389Q35899984-8ABCDC71-F152-4EBD-9364-3F4DA300A20EQ36258368-6F4D13B8-8847-4C9B-A3B1-13AB298CA608Q36529070-882BB9D1-1FD9-462B-968D-4E703CA382CFQ36930481-51F83A61-7E23-4B4A-939D-136EC7A9694CQ37058596-F127141A-04D9-43F9-B596-5266CB5FA88DQ37114576-7872A7BD-3F1B-426A-A450-0616F356B4FAQ37151791-95958B04-36C0-480E-AC42-CCC34B577859Q37196353-82F28A94-0A1F-4F30-AFF4-235762231C4EQ37205796-83B2E8F5-BCA0-4245-8494-B4B8B9F90793Q37310467-FCE25260-BA3E-43E9-89E0-709DF6C6ED35Q37712597-19F9FA5D-CCB7-452D-9D05-81E52C03A10EQ38089090-20F85593-2395-48EB-AD85-3A9642ED0625Q38124049-468946D3-555B-4522-B4E0-965810B9DCDBQ38128784-81801D90-552E-4722-97FC-34A17EC573ECQ38393039-FA6DF808-C2AD-4D85-9E93-792808F67EF3Q38667788-3F6AAF91-2EFB-4DA3-868A-0544A32D26B4Q39370185-42D2A125-CFE7-490B-8B4D-ADCB4A5BF15DQ39685580-8FF1D415-BF29-4C33-9F15-69724A401903Q41874178-A0DA7068-043E-44B2-9BB2-853088B96B8DQ41919865-E120BEE5-69A4-4B58-817A-229A464DFD30Q42788177-087D7D89-0352-4134-9763-C61F2C48DDA9Q42975066-A44BEEC3-BA8C-47DF-95DB-6BFD75122DE4Q42986839-52BB4D33-203E-4597-B789-880D6EABAC99Q45873443-3E31D8F5-C092-4433-8EE7-3354BD3CED7BQ53648300-3ACF77E1-F245-49BE-B17B-9661506E9DA8Q59136280-140C42BB-7965-4236-AA8E-BACC07495C4F
P2860
Experimental and clinical basis for the use of statins in patients with ischemic and nonischemic cardiomyopathy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Experimental and clinical basi ...... nd nonischemic cardiomyopathy.
@en
Experimental and clinical basi ...... nd nonischemic cardiomyopathy.
@nl
type
label
Experimental and clinical basi ...... nd nonischemic cardiomyopathy.
@en
Experimental and clinical basi ...... nd nonischemic cardiomyopathy.
@nl
prefLabel
Experimental and clinical basi ...... nd nonischemic cardiomyopathy.
@en
Experimental and clinical basi ...... nd nonischemic cardiomyopathy.
@nl
P2093
P1476
Experimental and clinical basi ...... nd nonischemic cardiomyopathy.
@en
P2093
Anita Deswal
Donna L White
Jerry Estep
Kumudha Ramasubbu
P304
P356
10.1016/J.JACC.2007.10.009
P407
P577
2008-01-01T00:00:00Z